http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2652821-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7f75780245ab029ad042060276ad22a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-50
filingDate 1976-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1469b9fe4ca144a62986109dcc28a77b
publicationDate 1978-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-2652821-A1
titleOfInvention THERAPEUTIC WITH BLOOD PRESSURE REDUCER AND / OR DIURETIC EFFECT AND PROCESS FOR MANUFACTURING THE ACTIVE SUBSTANCES
abstract Therapeutic compsns. contain as active component an imidazoline of formula (I) or its acid addition salt. In (I) R' and R2 are each H, halogen, 1-4C alkyl, 1-4C alkoxy or CF3. Prepf. of (I) and their salts comprises reacting a phenyl isocyanidedihalide (II) with 2-aminoethylhydroazine (III) and opt. reacting with acid. (I) are known intermediates for therapeutically active substd. 2-phenylamino-imidazoline-2 cpds. (DT 2220906). They have now been discovered to have hypotensive and/or diuretic activity, and are useful for treating chronic hypertension. In an example, 1-amin-2-(2,6-dichlorophenylamino)-imidazoline-2- was prepd. from the corresp. dichloride and (III).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5258381-A
priorityDate 1976-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18789707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432268812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415905043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416170937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415835321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415814097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154251973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121464265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449662972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2758167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410444838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53785868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID252504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420591870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465192876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416170491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2757800

Total number of triples: 42.